By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120



Drug Discovery

Company News
Cellectar Biosciences  (NVLT) To Present At The 17th Annual BIO CEO & Investor Conference 2015 2/6/2015 10:23:47 AM
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences  (NVLT) Fluorescence Cancer-Targeting Agents Chosen For The Cover Of Neurosurgery 1/22/2015 7:54:13 AM
Cellectar Biosciences  (NVLT) To Present At The Biotech Showcase 2015 Conference 1/9/2015 8:14:32 AM
Cellectar Biosciences  (NVLT) Granted Orphan Designation For I-131-CLR1404 For The Treatment Of Multiple Myeloma 12/5/2014 11:55:04 AM
Cellectar Biosciences  (NVLT) Names Cameron Szakacs, Ph.D. Vice President Of Clinical Development 11/25/2014 9:15:24 AM
Cellectar Biosciences  (NVLT) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014 7:53:45 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On November 11th To Discuss Third Quarter 2014 Results And Provide Quarterly Update On Development Progress 11/6/2014 1:13:37 PM
Cellectar Biosciences  (NVLT) Announces Publication Of Findings Demonstrating Efficacy Of Its Phospholipid Ether Analog Platform In Detecting Colorectal Cancer 10/15/2014 7:58:45 AM
Cellectar Biosciences  (NVLT) Announces Participation In Two Upcoming Investor Conferences In September 9/5/2014 8:01:16 AM
Cellectar Biosciences  (NVLT) Announces Acceptance Of Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma 9/4/2014 8:59:37 AM